Lehto VP - Search Results

1

Conjugation with carbon nanotubes improves the performance of mesoporous silicon as Li-ion battery anode.

Ikonen T, Kalidas N, Lahtinen K, Isoniemi T, Toppari JJ, Vázquez E, Herrero-Chamorro MA, Fierro JLG, Kallio T, Lehto VP. Ikonen T, et al. Among authors: lehto vp. Sci Rep. 2020 Mar 27;10(1):5589. doi: 10.1038/s41598-020-62564-0. Sci Rep. 2020. PMID: 32221406 Free PMC article.

2

Biomass-Based Silicon and Carbon for Lithium-Ion Battery Anodes.

Muraleedharan Pillai M, Kalidas N, Zhao X, Lehto VP. Muraleedharan Pillai M, et al. Among authors: lehto vp. Front Chem. 2022 May 4;10:882081. doi: 10.3389/fchem.2022.882081. eCollection 2022. Front Chem. 2022. PMID: 35601553 Free PMC article. Review.

3

Black Mesoporous Silicon as a Contrast Agent for LED-Based 3D Photoacoustic Tomography.

Xu W, Leskinen J, Tick J, Happonen E, Tarvainen T, Lehto VP. Xu W, et al. Among authors: lehto vp. ACS Appl Mater Interfaces. 2020 Feb 5;12(5):5456-5461. doi: 10.1021/acsami.9b18844. Epub 2020 Jan 22. ACS Appl Mater Interfaces. 2020. PMID: 31920072 Free PMC article.

4

Challenges and prospects of nanosized silicon anodes in lithium-ion batteries.

Zhao X, Lehto VP. Zhao X, et al. Among authors: lehto vp. Nanotechnology. 2021 Jan 22;32(4):042002. doi: 10.1088/1361-6528/abb850. Nanotechnology. 2021. PMID: 32927440

5

Mesoporous silicon in drug delivery applications.

Salonen J, Kaukonen AM, Hirvonen J, Lehto VP. Salonen J, et al. Among authors: lehto vp. J Pharm Sci. 2008 Feb;97(2):632-53. doi: 10.1002/jps.20999. J Pharm Sci. 2008. PMID: 17546667 Review.

6

In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles.

Kilpeläinen M, Riikonen J, Vlasova MA, Huotari A, Lehto VP, Salonen J, Herzig KH, Järvinen K. Kilpeläinen M, et al. Among authors: lehto vp. J Control Release. 2009 Jul 20;137(2):166-70. doi: 10.1016/j.jconrel.2009.03.017. Epub 2009 Apr 2. J Control Release. 2009. PMID: 19345247

7

Mesoporous silicon microparticles as carriers for peptides.

Kilpeläinen M, Mönkäre J, Riikonen J, Vlasova M, Salonen J, Lehto VP, Herzig KH, Järvinen K. Kilpeläinen M, et al. Among authors: lehto vp. J Control Release. 2010 Nov 20;148(1):e43-4. doi: 10.1016/j.jconrel.2010.07.050. J Control Release. 2010. PMID: 21529616 No abstract available.

8

Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.

Huotari A, Xu W, Mönkäre J, Kovalainen M, Herzig KH, Lehto VP, Järvinen K. Huotari A, et al. Among authors: lehto vp. Int J Pharm. 2013 Sep 15;454(1):67-73. doi: 10.1016/j.ijpharm.2013.06.063. Epub 2013 Jul 5. Int J Pharm. 2013. PMID: 23834832

9

In vitro dissolution methods for hydrophilic and hydrophobic porous silicon microparticles.

Mönkäre J, Riikonen J, Rauma E, Salonen J, Lehto VP, Järvinen K. Mönkäre J, et al. Among authors: lehto vp. Pharmaceutics. 2011 Jun 21;3(2):315-25. doi: 10.3390/pharmaceutics3020315. Pharmaceutics. 2011. PMID: 24310498 Free PMC article.

10

Cytotoxicity assessment of porous silicon microparticles for ocular drug delivery.

Korhonen E, Rönkkö S, Hillebrand S, Riikonen J, Xu W, Järvinen K, Lehto VP, Kauppinen A. Korhonen E, et al. Among authors: lehto vp. Eur J Pharm Biopharm. 2016 Mar;100:1-8. doi: 10.1016/j.ejpb.2015.11.020. Epub 2015 Dec 11. Eur J Pharm Biopharm. 2016. PMID: 26686646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

361 results

Search Page